Lower expression of cyclooxygenase-2: Is it associated with the development of borderline ovarian tumors?

Medical Hypotheses

Volumn 64, Issue 2, 2005, Pages 273-278

  Dursun, Polat ^a   Gultekin, Murat ^a   Yuce, Kunter ^a   Ayhan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BORDERLINE OVARY TUMOR; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; DISEASE ASSOCIATION; HUMAN; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MUTAGENESIS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 11144342332     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.06.031     Document Type: Article

References (40)

1. Jonathan S. Berek Ovarian cancer Jonathan S. Berek Novak Novak gynecology 13th ed. 2002 Wiliams & Wilkins Lippincott Philedelphia 1245
2. Epithelial ovarian carcinoma. In Philip J. Disaia, William T Creasman, editors. Clinical gynecologic oncology. 6th ed., Mosby Inc, p. 289
3. B. Singh, and A. Lucci Role of cyclooxygenase-2 in breast cancer Journal of Surgical Research 108 2002 2002 173 179
4. G. Ferrandina, F.O. Ranelletti, L. Lauriola, F. Fanfani, F. Legge, and M. Mottolese Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer Gynecologic Oncology 85 2002 305 310
5. Y.J. Chen, L.S. Wang, P.H. Wang, C.R. Lai, M.S. Yen, and H.T. Ng High cyclooxygenase-2 expression in cervical adenocarcinomas Gynecol Oncol 88 2003 379 385
6. S.M. Prescott, and F.A. Fitzpatrick Cyclooxygenase-2 and carcinogenesis Biochim Biophys Acta 1470 2 2000 M69 M78
7. S. Li, K. Miner, R. Fannin, J.C. Barrett, and B.J. Davis Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium Gynecol Oncol 92 2 2004 622 627
8. S. Mohan, and J.B. Epstein Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer Oral Oncol 39 6 2003 537 546
9. R.W. Brueggemeier, J.A. Richards, and T.A. Petrel Aromatase and cyclooxygenases: enzymes in breast cancer Steroid Biochem Mol Biol 86 3-5 2003 501 507
10. Y. Miyata, S. Koga, S. Kanda, M. Nishikido, T. Hayashi, and H. Kanetake Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival Clin Cancer Res 9 5 2003 1741 1749
11. O. Dormond, A. Foletti, C. Paroz, and C. Ruegg NSAIDs inhibit alpha V beta 3 integrin- mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis Nat Med 7 9 2001 1041 1047
12. X.Z. Ding, R. Henning, and T.E. Adrian Lipoxygenase and cyclooxygenase metabolism: new insight in treatment and chemoprevention of pancreatic cancer Mol Cancer 2 2003 10
13. A. Ferrandez, S. Prescott, and R.W. Burt COX-2 and colorectal cancer Curr Pharm Des 9 27 2003 2229 2251
14. R. Leach, B. Pollock, J. Basler, D. Troyer, S. Naylor, and I.M. Thompson Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials Urol Clin North Am 30 2 2003 227 237
15. J. Okami, S. Nakamori, H. Yamamoto, M. Sakon, M. Tsujie, and N. Hayashi An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas J Exp Clin Cancer Res 21 4 2002 569 576
16. K. Saukkonen, J. Rintahaka, A. Sivula, C.J. Buskens, B.P. Van Rees, and M.C. Rio Cyclooxygenase-2 and gastric carcinogenesis APMIS 111 10 2003 915 925
17. J.E. Castelao, R.D. Bart III, C.A. DiPerna, E.M. Sievers, and R.M. Bremner Lung cancer and cyclooxygenase-2 Ann Thorac Surg 76 4 2003 1327 1335
18. K. Shigemasa, X. Tian, L. Gu, Y. Shiroyama, N. Nagai, and K. Ohama Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas Int J Oncol 22 1 2003 99 105
19. L.M. Kmet, L.S. Cook, and A.M. Magliocco A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors Cancer 97 2 2003 389 404
20. J. Diebold, F. Seemuller, and U.K. Lohrs RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy Lab Invest 83 2 2003 251 258
21. H. Sheng, J. Shao, and R.N. Dubois K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1 Cancer Res 61 6 2001 2670 2675 Mar 15
22. I. Morita Distinct functions of COX-1 and COX-2 Prostaglandins Lipid Mediators 68-69 2002 165 175
23. A.R. Munkarah, R. Morris, P. Baumann, G. Deppe, J. Malone, and M.P. Diamond Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells J Soc Gynecol Investig 9 3 2002 168 173 May-Jun
24. H. Sheng, J. Shao, J.D. Morrow, R.D. Beauchamp, and R.N. DuBois Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Res 58 2 1998 362 366 Jan 15
25. M.T. Lin, R.C. Lee, P.C. Yang, F.M. Ho, and M.L. Kuo Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway J Biol Chem 276 52 2001 48997 49002 Epub 2001 Oct 03, Dec 28
26. M.P. Schrey, and K.V. Patel Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators Br J Cancer 72 6 1995 1412 1419
27. W.G. Tong, X.Z. Ding, R. Hennig, R.C. Witt, J. Standop, and P.M. Pour Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells Clin Cancer Res 8 10 2002 3232 3242
28. X. Tang, Y.J. Sun, E. Half, M.T. Kuo, and F. Sinicrope Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells Cancer Res 62 17 2002 4903 4908
29. R.A. Sharma, A. Gescher, J.P. Plastaras, C. Leuratti, R. Singh, and B. Gallacher-Horley Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells Carcinogenesis 22 9 2001 1557 1560
30. F.W. Wiese, P.A. Thompson, and F.F. Kadlubar Carcinogen substrate specificity of human COX-1 and COX-2 Carcinogenesis 22 1 2001 5 10
31. P.K. Lala, and C. Chakraborty Role of nitric oxide in carcinogenesis and tumour progression Lancet Oncol 2 3 2001 149 156
32. L.C. Jadeski, C. Chakraborty, and P.K. Lala Role of nitric oxide in tumour progression with special reference to a murine breast cancer model Can J Physiol Pharmacol 80 2 2002 125 135
33. M. Sonoshita, K. Takaku, N. Sasaki, Y. Sugimoto, F. Ushikubi, and S. Narumiya Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC(Delta 716) knockout mice Nat Med 7 2001 1048 1051
34. T.O. Daniel, H. Liu, J.D. Morrow, B.C. Crews, and L.J. Marnett Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis Cancer Res 59 18 1999 4574 4577
35. E. Spisni, C. Griffoni, S. Santi, M. Riccio, R. Marulli, and G. Bartolini Colocalization prostacyclin (PGI2) synthase-caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis Exp Cell Res 266 1 2001 31 43
36. D. Nie, M. Lamberti, A. Zacharek, L. Li, K. Szekeres, and K. Tang Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis Biochem Biophys Res Commun 267 1 2000 245 251
37. S. Ali, M.G. Davis, M.W. Becker, and G.W. Dorn 2nd Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor J Biol Chem 268 23 1993 17397 17403
38. G. Chen, R. Wilson, J.H. McKillop, and J.J. Walker The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells Immunol Invest 23 4-5 1994 269 279
39. M.K. Jones, H. Wang, B.M. Peskar, E. Levin, R.M. Itani, and I.J. Sarfeh Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat Med 5 12 1999 1418 1423
40. S. Hauptmann, and M. Dietel Serous tumors of low malignant potential of the ovary-molecular pathology: part 2 Virchows Arch 436 5 2000 403 412